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Abstract
Purpose Regenerative strategies aim to restore the ori-
ginal biofunctionality of the intervertebral disc. Different
biomaterials are available, which might support disc
regeneration. In the present study, the prospects of success
of two hydrogels functionalized with anti-angiogenic pep-
tides and seeded with bone marrow derived mononuclear
cells (BMC), respectively, were investigated in an ovine
nucleotomy model.
Methods In a one-step procedure iliac crest aspirates
were harvested and, subsequently, separated BMC were
seeded on hydrogels and implanted into the ovine disc. For
the cell-seeded approach a hyaluronic acid-based hydrogel
was used. The anti-angiogenic potential of newly devel-
oped VEGF-blockers was investigated on ionically cross-
linked metacrylated gellan gum hydrogels. Untreated discs
served as nucleotomy controls. 24 adult merino sheep were
used. After 6 weeks histological, after 12 weeks histolog-
ical and biomechanical analyses were conducted.
Results Biomechanical tests revealed no differences
between any of the implanted and nucleotomized discs. All
implanted discs significantly degenerated compared to
intact discs. In contrast, there was no marked difference
between implanted and nucleotomized discs. In tendency,
albeit not significant, degeneration score and disc height
index deteriorated for all but not for the cell-seeded
hydrogels from 6 to 12 weeks. Cell-seeded hydrogels
slightly decelerated degeneration.
Conclusions None of the hydrogel configurations was
able to regenerate biofunctionality of the intervertebral
disc. This might presumably be caused by hydrogel
extrusion. Great importance should be given to the devel-
opment of annulus sealants, which effectively exploit the
potential of (cell-seeded) hydrogels for biological disc
regeneration and restoration of intervertebral disc
functioning.
Keywords Intervertebral disc  Degeneration 
Regeneration  One-step  Sheep  Large animal
model  In vivo
Introduction
Intervertebral disc degeneration (IDD) is a highly relevant
individual and socioeconomic burden, which is associated
to various morphological and functional disturbances [1].
The gradual progression of the disease and the structural
features, e.g., the degradation of proteoglycans with sub-
sequent desiccation of the disc extracellular matrix, the
ingrowth of blood vessels and the loss of intervertebral disc
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(IVD) height, can be addressed in close detail and predis-
pose IDD for regenerative strategies [2].
Currently, different approaches are being pursued to
regenerate the IVD. Direct injection of growth factors, viral
vectors and cells, each alone or in combination, seek to
stimulate proliferation and production of extracellular
matrix [3]. Reasonable chances of success of these meth-
ods, however, are questionable [4, 5]. Low oxygen and pH
within the avascular disc represent a hostile environment
for cell metabolism [2, 6, 7]. Conversely, vascularization
must not be promoted as it accelerates degeneration [8, 9].
Furthermore, aberrant mechanical stimuli may activate
catabolic remodelling, cell death and tissue breakdown
[10–13].
To reestablish a loading regime that enhances the ana-
bolic response of resident and implanted cells and to trigger
biological mechanisms of self-healing, biodegradable
substitutes were designed according to the natural ideal of
the IVD. As the restoration of disc height is assumed to be
essential for nucleus replacements, sufficient quantities of
hydrogels are intended to be injected into the IVD for an
immediate restoration of disc mechanics. Biomaterial
extrusion, however, is of major biomechanical concern
[14–16]. Hyaluronic acid or polysaccharide-based hydro-
gels, such as gellan gum-based hydrogels, were proven to
adequately support the growth and extracellular matrix
deposition of cells and might therefore be suited as nucleus
replacements [17–19]. To retain avascularity of cartilagi-
nous tissues, functionalization of scaffolds with anti-
angiogenic peptides was suggested [20].
To gain deeper knowledge on future research directions,
the purpose of this study was to investigate newly devel-
oped hydrogels as nucleus replacements for the biome-
chanical restoration and biological regeneration of the disc.
Different modifications of hydrogels were examined in an
ovine nucleotomy model. The effect of functionalization
on the efficiency of hydrogels was evaluated using anti-
angiogenic peptides and bone marrow derived mononu-
clear cells.
Materials and methods
24 adult Merino sheep (2–4.5 years; 76–108 kg) were
operated to compare four different hydrogel configurations
with nucleotomy controls. Permission for the animal
experiment was received from the regional commission of
Tu¨bingen (Reg. Nr. 1032).
Configuration 1 Hydrogels made of ionic crosslinked
methacrylated Gellan Gum (iGG-MA; 3B’s Research Group,
University of Minho, Portugal) were used as nucleus
replacement. iGG-MA is a microbial polysaccharide, which
forms a colloidal gel in the presence of metallic ions.
Configuration 2 To investigate whether anti-angiogenic
peptides reveal a positive effect in the prevention of IDD,
iGG-MA was functionalized with non-cytotoxic polyly-
sine-based VEGF-blockers (iGG-MA?PEP) that were
shown to effectively inhibit endothelial cell proliferation
[20] (School of Pharmacy and Biomolecular Sciences,
University of Brighton, United Kingdom).
Configuration 3 Hydrogels made of dodecyl-amide of
hyaluronic acid (DDAHA; Anika Therapeutics, Abano
Therme, Italy) were tested without additives.
Configuration 4 For the cell-based approach, DDAHA
was seeded with autologous bone marrow derived mono-
nuclear cells (DDAHA?BMC). A one-step surgical pro-
cedure was performed combining the harvesting of bone
marrow (BM) from the iliac crest, the isolation of BMC
and the orthotopic implantation of DDAHA?BMC.
Configuration 5 Nucleotomy control with no treatment.
The detailed composition of the hydrogels was previ-
ously described [21].
Preparation of cell-seeded scaffolds
In 18 animals one of four operated IVD received a cell-
seeded hydrogel. BM was harvested from the iliac crest
under sterile conditions at the beginning of surgery.
Coagulation was prevented by 5,000 IU heparin/10 ml BM
(Heparin-Natrium-5,000-ratiopharm, ratiopharm GmbH,
Ulm, Germany).
BMC (‘‘buffy coat’’) were isolated by buoyant density
separation. The cell-seeded hydrogels were prepared by
adding 0.25 ml of the cell suspension containing 4 9 106
BMC/ml PBS to 0.5 ml of DDAHA, resulting in 1 9 106
BMC/DDAHA. Control samples (DDAHA) were mixed
with 0.25 ml PBS without cells. Both hydrogels were
transferred in sterile 2 ml syringes for intraoperative
application. For the estimation of the number of mesen-
chymal stem cells (MSC) in BMC a colony forming units-
fibroblast (CFU-F) assay was performed as previously
described [22].
Orthotopic implantation of hydrogels
All animals were operated in four levels from L1–L2 to
L4–L5 or in case of 7 lumbar vertebrae (n = 8) from L2–
L3 to L5–L6. General anesthesia and the retroperitoneal
multisegmental approach to the spine were performed as
recently described in detail [23]. Each disc was stabbed
with sterile microsurgery blades and a lateral nucleotomy
was performed using 1.0 and 1.5 mm rongeurs with
straight and flexed jaws, respectively. Approximately
0.20 g (0.17–0.23 g) nucleus tissue was removed from
each disc and treated in an alternating sequence with one of
the five configurations (Fig. 1). The annulus defects were
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closed with suture and 2-octyl-cyanoacrylate glue
(DERMABOND, Ethicon Products, Norderstedt, Ger-
many) and covered with a collagen sponge (Lyostypt,
Aesculap AG, Tuttlingen, Germany).
Eight animals were sacrificed after 6 weeks for only
histological and 16 sheep after 12 weeks for histological
and biomechanical analyses. The 6-week group for bio-
mechanics was omitted because after this time period
annulus healing is not to be expected [24].
For biomechanical and histological comparison with
intact discs, respectively, six native lumbar spines and six
lumbar segments from independent comparable sheep were
used.
Biomechanics
For the biomechanical analyses, the polysegmental speci-
mens including all treated discs were embedded in poly-
methylmethacrylate (PMMA, Technovit 3040, Heraeus
Kulzer, Werheim, Germany) and tested in a custom-made
spine loading simulator [25, 26]. The range of motion
(RoM) and the neutral zone (NZ) were investigated for
each segment separately at ±7.5 Nm pure moments in the
three principal motion planes flexion ? extension, lateral
bending right ? left, and axial rotation left ? right using a
motion tracking system (Vicon MX13, Vicon, Oxford,
United Kingdom).
Histology
For qualitative and semi-quantitative histological evalua-
tion each segment was embedded in PMMA for undecal-
cified histology after formalin fixation. Giemsa
staining was performed using standard protocols. An
established semi-quantitative degeneration score according
Fig. 1 Alternating implantation scheme for the two hydrogels (blue, green) without (light) and with peptides or cells (dark) and the nucleotomy
controls (red)
Table 1 Modified degeneration score according to Boos et al. [27]
Degeneration
parameter
Characteristic feature Score
(total 36)
Intervertebral disc
Cells No proliferation/ 0
Increased cell density/ 1
Connection of two
chondrocytes/
2
Small size clones/ 3
Moderate size clones/ 4
Huge size clones 5
Granular changes None/rare/intermediate/
abundantly
0/1/2/3
Neovascularization Absent/present 0/1
Rim lesions None/rare/intermediate/
abundantly
0/1/2/3
Concentric tears None/rare/intermediate/
abundantly
0/1/2/3
Radial tears None/rare/intermediate/
abundantly
0/1/2/3
Scar formation Absent/present 0/1
Tissue defects Absent/present 0/1
Endplate
Cells None/rare/intermediate/
abundantly
0/1/2/3
Structural
disorganization
None/rare/intermediate/
abundantly
0/1/2/3
Clefts None/rare/intermediate/
abundantly
0/1/2/3
Microfracture None/rare/intermediate/
abundantly
0/1/2/3
Neovascularization Absent/present 0/1
New bone formation Absent/present 0/1
Scar formation Absent/present 0/1
Tissue defects Absent/present 0/1
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to Boos et al. [27] was used to determine the degree of
degeneration (Table 1). The disc height index (DHI) was
evaluated by dividing the mean value of the anterior,
middle and posterior disc height from the histologic sam-
ples by the anterio-posterior diameter of the disc using
ImageJ software [28]. Inflammation parameters, such as the
presence of immune cells, regeneration of the tissue, blood
vessel formation and remaining hydrogels were qualita-
tively evaluated under light microscopy (DMI6000B, Le-
ica, Heerbrugg, Switzerland).
Statistics
For statistical analysis the unpaired, two-sample Wilcoxon
signed rank test to a significance level of p B 0.05 was
used. Statistics were performed using GnuR [29].
Results
Surgical interventions were well tolerated by the sheep.
Intra- or post-operative complications did not occur.
Cell isolation
The yields of BMC/ml BM and the frequency of MSC
evaluated by CFU-F assay varied considerably between the
sheep. The mean ± SD of BMC/ml BM was 1.11 9 106 ±
0.95 9 106. The cloning efficiency of BMC population var-
ied between 0.0008–0.039 % CFU-F (mean 0.01 ± 0.01 %).
This resulted in the mean of 101 ± 108 MSC/hydrogel and
varied between 8 and 390 MSC/hydrogel. In average 0.20 ml
(0.19–0.21 ml) of the cell-seeded hydrogels could be injected.
The estimated number of BMC injected by DDAHA ? BMC
treatment therefore was about 270,000.
Biomechanics
After 12 weeks in vivo, nucleotomy significantly decreased
RoM compared to intact discs in flexion ? extension
(p = 0.02) and lateral bending (p = 0.04; Fig. 2), but not
in axial rotation. Significant decreased RoM was also found
for iGG-MA ? PEP in flexion ? extension (p = 0.03) and
lateral bending (p = 0.02). RoM for iGG-MA and
DDAHA was significantly lower only in flexion ? exten-
sion (p = 0.04 and 0.01, respectively). DDAHA ? BMC
did not show significant differences at all. Compared to
nucleotomy controls none of the hydrogel implanted discs
revealed significant differences.
Histology
Histological sections showed marked differences between
the surgically affected and intact discs 12 weeks after
surgery. The structural integrity was obviously impaired in
operated discs (Fig. 3). Tissue defects within the nucleus
were similar in size in nucleotomy controls and hydrogel
implanted discs. Hydrogels could not unambiguously be
identified within the histological sections. Huge size cell
clones were located in immediate vicinity of tissue defects
inside the remaining nucleus pulposus tissue. Inflammation
could not be found in any of the investigated samples.
Fig. 2 Total ranges of motion
(RoM) and neutral zones (NZ)
in flexion ? extension (flex/ex),
lateral bending right ? left (lat
bend) and axial rotation
left ? right (ax rot) for intact
discs of separate sheep (green
background) and for the five test
configurations investigated in
the current study. *p \ 0.05
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Marked neovascularisation did not occur in any of the
operated discs and, therefore, differences between the
hydrogel implanted discs and the nucleotomy controls were
not found. No differences in cellularity were seen. There
was no visible formation of spondylophytes or bony end-
plate changes up to 12 weeks.
Intact discs revealed with a median degeneration score
of 3.5 only negligible degenerative changes within the disc
(Fig. 4). The degeneration score of all implanted and nu-
cleotomized discs significantly differed from intact discs
(p = 0.003–0.005). In contrast, there was no marked dif-
ference between the implanted discs and nucleotomy con-
trols, neither after 6 nor 12 weeks. Comparing the results
after 6 to results after 12 weeks, there was an obvious
(although not significant) increase in the degeneration
scores of nucleotomy controls (17 %) and all acellular test
configurations (13–35 %). In DDAHA ? BMC degenera-
tion scores were kept almost constant.
DHI of intact discs were with 0.19 (0.16–0.25) signifi-
cantly higher than all operated discs at both time intervals
(Fig. 5). After 6 weeks DHI of nucleotomy controls fell by
28 % compared to intact discs. DHI of hydrogel implanted
discs decreased in a similar range (iGG-MA: -33 %, iGG-
MApep: -30 %, DDAHA: -27 %; DDAHA ? BMC
-35 %). From 6 to 12 weeks post-operatively there was a
progressive decrease in DHI for acellular hydrogels (iGG-
MA: -9 %, iGG-MApep: -8 %, DDAHA: -9 %). DHI in
DDAHA ? BMC, however, seemed to be preserved
(?2 %) even if this effect was not significant. Nucleotomy
controls lost 11 % of DHI between 6 and 12 weeks.
Fig. 3 Representative mid-sagittal histological sections of operated discs 12 weeks after surgery in comparison to an intact disc
Fig. 4 Degeneration scores of intact discs (dashed line) were
significantly less than of nucleotomy controls and hydrogel implanted
discs (p = 0.003 – 0.005). There was no difference between nucle-
otomy controls and the four different material configurations both
after 6 (white) and 12 weeks (grey)
Fig. 5 Disc height indices of intact discs (dashed line) significantly
differed from nucleotomy controls and hydrogel implanted discs
(p = 0.003 – 0.013). No difference between nucleotomy controls and
the different material configurations was found both 6 (white) and
12 weeks (grey) post-operatively
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Discussion
In this study using an ovine nucleotomy model, different
configurations of newly developed hydrogels for nucleus
replacements were investigated for their ability to restore
RoM and disc height and to slow down IDD.
Results consistently showed that none of the tested
hydrogel configurations proved to be superior to nucleot-
omy controls. The treatment with hydrogels was not able to
restore disc height. However, against expectation, the
operated discs showed a smaller ROM than intact discs.
Histology of hydrogel implanted discs (acellular and cel-
lular) showed more signs of degeneration as intact discs.
There was a slight tendency that using BMC may eventu-
ally slow down IDD between 6 and 12 weeks of
implantation.
The higher RoM of intact compared to nucleotomized
discs found in this in vivo study is in contrast to in vitro
data in literature, where RoM significantly increased after
nucleotomy both for human [30] and for calf specimen [14,
31]. The same tendency was also found for ovine specimen
in preliminary in vitro investigations for the current study
(unpublished data). The discrepancy may be explained by
general differences between in vitro conditions without
healing, and the in vivo situation where collagenous
bridges at the outer annulus were described 12 weeks after
injury [32]. This initial bridging and the formation of scar
tissue as well as the sealant method might be the reasons
for the increased stiffness observed in this in vivo study.
The evaluation of the disc height index clearly proved
that up to 12 weeks restoration of disc height could not be
achieved using different hydrogel configurations as nucleus
replacements after nucleotomy. This finding strongly
indicates that relevant amounts of hydrogels were probably
pressed out of the disc. This challenging problem of
implant extrusion may also explain the similar disap-
pointing degeneration scores both for the nucleotomy
controls as well as for the hydrogel implanted discs.
Partial removal of nucleus was required for implantation
of hydrogels as pure injection of a relevant amount of
substitute materials into the healthy ovine disc is impos-
sible because no cavity is available and intradiscal pressure
in vivo is high [23]. Opening the annulus, however, inev-
itably causes the problem of extrusion. Sealants that reli-
ably keep nucleus replacements inside the disc are urgently
needed, but still not available. In previous in vitro studies,
we have shown that the best of tested sealant options was
cyanoacrylate glue combined with surgical suture [15].
Under axial compression, however, this sealant still
allowed for gaping of the inner annulus defect with sub-
sequent dislocation of implanted hydrogels and loss of
intradiscal pressure in ovine motion segments [21]. To
enhance the sealant efficiency in the current study, the
closed defect was additionally covered with a collagen
sponge. Artificial closure devices, proven to be effective to
restore disc mechanics in vitro, unfortunately contradict to
the main objective of disc regeneration and therefore were
not used in the current study [33, 34].
Disc regeneration using hydrogels could not be achieved
with this ovine nucleotomy model. This is in contrast to
other animal experiments with rodents or pigs [35, 36].
These different findings may be explained by the persis-
tence of notochordal progenitor cells within the discs of
these animals. Because in humans and likewise in sheep
this cell type disappears, conclusions from the above
mentioned species should be transferred to humans with
caution [37, 38]. Similar biology as well as similar anat-
omy and biomechanics suggest the sheep to be a more
relevant model for humans [39–42].
The potential positive effect of BMC as additive in
hydrogels for disc regeneration should be interpreted
carefully. Only about 25 MSC/disc (range 2–70) provided
in approximately 270,000 BMC have been implanted. The
optimal number of bone marrow derived MSC to be
implanted into the degenerated disc to achieve a stimulat-
ing effect was found to be 106 in dogs [43]. However, MSC
yields in this order of magnitude are impossible to achieve
without in vitro expansion. Low cell density applied is
assumed to be the reason for limited observed effects.
In vitro expansion of BMC prior to surgery might have
reinforced the trends. The nevertheless promising per-
spectives of cell-based approaches for disc regeneration are
in accordance to literature [44, 45]. The right cell source,
however, is still not finally clarified [46]. The BMC pop-
ulation used in the current study is a broad mixture of cell
lineages in different differentiation stages containing
multipotent mesenchymal and hemopoietic stem cells.
Beneficial effects might be mediated by differentiation of
MSC into IVD cells. Furthermore, BMC may act as trophic
factor pools. Paracrine effects may cause BMC to secrete
growth factors, cytokines and chemokines capable of
stimulating the regeneration of injured tissue [47–49].
In case that the slight trend found in this study can be
supported with future research, the perspective of applying
non-cultivated BMC for disc regeneration in humans might
be promising. Using the patients’ own and unmodified cells
might be an interesting solution which would probably lead
to higher compliance of this new potential therapeutic
option [50–52].
Injected cells were not labelled in the current study. As
with the hydrogels, the fate of BMC after injection is,
therefore, not known. This limitation is owed to the one-
step surgical procedure using BMC without in vitro
cultivation.
The durations of the animal study with 6 and 12 weeks
may eventually have been too short to represent the
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regenerative capacity of the different hydrogel configura-
tions. Longer test durations are therefore recommended
when investigating biological strategies.
Conclusion
The results of present study indicate that because of pre-
sumed hydrogel extrusion, none of the investigated
hydrogels was able to slow down IDD compared to nu-
cleotomized discs. Therefore, the development of effective
annulus sealants is crucial for successful nucleus replace-
ment using hydrogels. Additional studies are recommended
to substantiate the effects of non-cultivated cells for disc
regeneration.
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